Loading…
Astec LifeSciences (ASTEC)₹527.20−7.07%Pesticides & Agrochemicals
At the end of the Sep 2026 quarter, Astec LifeSciences' shareholders were: promoters 71.96%, FIIs 0.02%, DIIs 3.35%, public 24.67%. Promoter holding is unchanged on the quarter. FII holding is up 0.02 percentage points from 0.00% a year earlier. 0.00% of promoter shares were pledged. It had 19,698 shareholders.
As of · Company filings (shareholding pattern)
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 66.74% | 66.74% | 66.74% | 66.73% | 66.73% | 70.86% | 70.86% | 72.41% | 71.96% | 71.96% | 71.96% | 71.96% |
| FIIs | 1.27% | 1.24% | 1.02% | 0.53% | 1.19% | 0.25% | 0.02% | 0.00% | 0.04% | 0.03% | 0.01% | 0.02% |
| DIIs | 9.75% | 7.89% | 3.38% | 4.51% | 5.41% | 4.35% | 4.27% | 4.02% | 3.18% | 3.34% | 3.34% | 3.35% |
| Public | 22.24% | 24.13% | 28.86% | 28.23% | 26.67% | 24.54% | 24.85% | 23.57% | 24.82% | 24.67% | 24.69% | 24.67% |
| Promoter shares pledged | — | — | — | — | — | — | — | — | — | — | — | 0.00% |
| Number of shareholders | 19,235 | 19,839 | 19,946 | 19,718 | 19,048 | 18,681 | 18,541 | 18,268 | 22,283 | 21,031 | 19,880 | 19,698 |
| Holder | Category | Sep 2026 | Change (pp) |
|---|---|---|---|
| Godrej Agrovet Limted | Promoter | 66.99% | 0.00 |
| Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund | DII | 2.34% | 0.00 |
| Nadir Burjor Godrej | Promoter | 1.83% | 0.00 |
| Ashok Vishwanath Hiremath | Promoter | 1.30% | 0.00 |
| Kifs Trade Capital Private Limited | Public | 1.01% | New |
| Nisaba Godrej | Promoter | 0.61% | 0.00 |
| Pirojsha Adi Godrej | Promoter | 0.61% | 0.00 |
| Tanya Arvind Dubash | Promoter | 0.61% | 0.00 |
| Ajay Kumar Aggarwal | Public | Exited | — |
Promoters held 71.96% of Astec LifeSciences at the end of the Sep 2026 quarter, down 0.45 percentage points from 72.41% a year earlier.
In the Sep 2026 quarter, foreign institutional investors (FIIs) held 0.02% (up 0.01 percentage points from 0.01% a quarter earlier) and domestic institutions (DIIs) held 3.35% (up 0.01 percentage points from 3.34% a quarter earlier).
No. The Sep 2026 filing shows no pledged promoter shares.
Astec LifeSciences had 19,698 shareholders at the end of the Sep 2026 quarter, against 18,268 a year earlier.
Nippon Life India Trustee Ltd-A/C Nippon India Small Cap Fund (DII) held 2.34% at the end of the Sep 2026 quarter, the largest named holding outside the promoter group.